Denmark· DK-28106964923
Amikacin "Orifarm"
A amikacin product containing amikacinsulfat, registered in Denmark by Orifarm A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Amikacin · ATC J01GB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Amikacinsulfat
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- J01GB06
- ATC class
- Amikacin
- Defined daily dose
- 0.59 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106964923
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for amikacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amikacin · interactions on record
253 records
- 50 severe
- 133 moderate
- 2 minor
- 68 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01GB06
Amikacin, as other registers publish it.
- DenmarkAmikacin "Afortas"2care4 Generics ApS
- DenmarkAmikacin "Macure"Macure Pharma ApS
- DenmarkAmikacin "Medartuum"Medartuum AB
- IrelandAmikacin 125 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- IrelandAmikacin 250 mg/ ml Solution for injection/infusionAthlone Pharmaceuticals Limited
- IrelandAmikacin 250 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- United KingdomAmikacin 25mg/5ml solution for injection ampoulesSpecial Order
- United KingdomAmikacin 25mg/5ml solution for injection pre-filled syringesSpecial Order
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f4aff00-e795-4a8b-ad3b-af9ecd28acb0 GET /v1/drugs/1f4aff00-e795-4a8b-ad3b-af9ecd28acb0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "250 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28106964923",
"substance": "Amikacinsulfat",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45303"
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.